Exogenous lactate

Exogenous lactate, sometimes referred to as Exolactate, is L-lactate that is supplied to the body from an external source, typically as an oral supplement or, in research and medical settings, by intravenous infusion.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 3 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Exogenous lactate, sometimes referred to as Exolactate, is L-lactate that is supplied to the body from an external source, typically as an oral supplement or, in research and medical settings, by intravenous infusion. It has been investigated as a potential ergogenic aid in endurance sports, as a recovery substrate and as a metabolic intervention in clinical contexts such as traumatic brain injury and metabolic disease.

Leading researchers in this field include scientists such as George Brooks, L. Bruce Gladden, Joshua Rabinowitz, Inigo San Millán and Sheng Tony Hui. Lactate has been historically described as a waste product, associated with muscle fatigue and acidosis.

The lactate shuttle theory, developed primarily by George A. Brooks during the 1980s and 1990s, reframed lactate as a circulating energy substrate that is exchanged between glycolytic and oxidative tissues, whilst also acting as a signalling molecule. Within this framework, lactate produced in one tissue can be oxidised in another via monocarboxylate transporters (MCTs).

Most circulating lactate is produced endogenously (within the body), however humans can also absorb lactate from the gut.…

Exogenous lactate, sometimes referred to as Exolactate, is L-lactate that is supplied to the body from an external source, typically as an oral supplement or, in research and medical settings, by intravenous infusion. It has been investigated as a potential ergogenic aid in endurance sports, as a recovery substrate and as a metabolic intervention in clinical contexts such as traumatic brain injury and metabolic disease.

Leading researchers in this field include scientists such as George Brooks, L. Bruce Gladden, Joshua Rabinowitz, Inigo San Millán and Sheng Tony Hui. Lactate has been historically described as a waste product, associated with muscle fatigue and acidosis.

The lactate shuttle theory, developed primarily by George A. Brooks during the 1980s and 1990s, reframed lactate as a circulating energy substrate that is exchanged between glycolytic and oxidative tissues, whilst also acting as a signalling molecule. Within this framework, lactate produced in one tissue can be oxidised in another via monocarboxylate transporters (MCTs).

Most circulating lactate is produced endogenously (within the body), however humans can also absorb lactate from the gut. Exogenous lactate enters systemic circulation through intestinal MCTs, predominantly MCT1, whereupon it is rapidly converted to pyruvate by lactate dehydrogenase, before entering the tricarboxylic acid (TCA) cycle in mitochondria.

Researchers have proposed that, provided it is delivered safely and at sufficient rates (10–25 g per hour), exogenous lactate could complement carbohydrate-based fuelling during prolonged endurance exercise. Hypothesised to be possible due to the intestinal absorption of lactate using transporters independent of those used by glucose and fructose.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1368204657 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

4 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.